Skip to search formSkip to main contentSkip to account menu

DQ 2511

Known as: DQ-2511 
National Institutes of Health

Related topics

Related topics

1 relation

Broader (1)

ecabapide

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
1997
1997
Possible mechanisms underlying the suppression of gastric vagal afferents due to ecabapide (DQ-2511), a gastroprokinetic agent, in rats.
We examined the implication of a nitric oxide (NO)-guanosine 3',5'-cyclic monophosphate (cGMP) cascade in the suppression of… 
Review
1997
Review
1997
Pharmacology of the Gastric Pro‐kinetic Drug Ecabapide (DQ‐2511)
The pharmacology of ecabapide (DQ‐2511; 3‐[2‐(3,4‐dimethoxyphenyl)ethylcarbamoylmethyl]amino‐N‐methylbenzamide) is reviewed. 
1997
1997
Effects of DQ-2511, a novel prokinetic agent, on electrical activities of smooth muscle in the guinea pig stomach.
Electrophysiological experiments were carried out to investigate the prokinetic actions of DQ-2511 on isolated smooth muscle of… 
1996
1996
Effects of DQ-2511 on neutral activity in afferent and efferent loops of gastric vago-vagal reflex pathways in the rat.
1. DQ-2511 is a new substituted benzamide compound that has gastric prokinetic properties. Actions of the drug on neural… 
1995
1995
Pharmacological characteristics of DQ-2511 as a prokinetic agent.
The pharmacological characteristics of DQ-2511, a substituted benzamide (3-[[[2-(3,4-dimethoxyphenyl)ethyl]carbamoyl]methyl… 
1995
1995
DQ-2511, having an antiulcer action, elicits vasodilation through an increase in cyclic GMP contents in rat arteries.
It has been reported that 3-(([2-(3,4-dimethoxyphenyl)ethyl]carbamoyl)methyl)amino-N-methylbenz amide (DQ-2511: ecabapide… 
1993
1993
Heinz body hemolytic anemia induced by DQ-2511, a new anti-ulcer drug, in dogs.
DQ-2511, a new anti-ulcer drug, was administered to beagle dogs for 4 weeks to investigate the mechanism whereby this drug… 
1993
1993
Cardiovascular properties of the new anti-ulcer drug 3-[[[2-(3,4-dimethoxyphenyl)ethyl]carbamoyl]methyl]-amino-N- methylbenzamide.
Cardiovascular activities of 3-[[[2-(3,4-dimethoxyphenyl)ethyl]carbamoyl]methyl]-amino-N- methylbenzamide (DQ-2511, CAS 104775-36… 
1992
1992
Syntheses of 2-(3,4-dimethoxyphenyl)ethylamine derivatives and their antiulcer activities.
A series of acyl derivatives of 2-(3,4-dimethoxyphenyl)ethylamine (4) were synthesized and evaluated for their effectiveness to… 
1990
1990
Antiulcer effects of 3-[[[2-(3,4-dimethoxyphenyl)ethyl] carbamoyl]methyl]-amino-N-methylbenzamide in experimental gastric and duodenal ulcers.
Effects of 3-[[[2-(3,4-dimethoxyphenyl)ethyl]carbamoyl] methyl]-amino-N-methylbenzamide (DQ-2511), a newly synthesized compound… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)